$67.740
+0.190 (+0.28%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BBIO por análisis de gráficos similares
Alphio's BBIO stock price prediction model matches the current BridgeBio Pharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $68.20 (+0.12%). The 1-week path is $65.55 (-3.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BridgeBio Pharma, Inc.?
BridgeBio Pharma Inc is a good buy right now due to its current price of $66.39, which is significantly lower than the analyst price targets ranging from $94 to $157. The company has shown a gross margin of 93.83% in Q2 2026, indicating strong profitability potential. Additionally, the recent partnership with the U.S. government to enhance drug access could drive future revenue growth. However, the main risk is the negative net income, which was -$155,891,000 in Q2 2026, indicating ongoing financial challenges that investors should monitor closely.
BBIO cerró en $67.74 el Wednesday, tras subir +0.28%
BridgeBio Pharma, Inc. (BBIO) last closed at $68.12, gaining +0.56%. These facts feed the 1-day and 1-week BBIO price prediction above.
Factores de la previsión
Los factores de la previsión de BridgeBio Pharma, Inc. (BBIO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BBIO, ordenadas por similitud.
Análisis de estacionalidad de BBIO
Historically the probability of a positive October return for BBIO is 36.51%. August offers the highest probability of a positive month at 62.50%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BBIO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $42.99 | $49.52 | $49.80 | -27.31% |
| Nov 2026 | $55.17 | $56.66 | $60.27 | -16.82% |
| Dec 2026 | $54.39 | $62.38 | $75.53 | -8.42% |
En 2026, se proyecta que BridgeBio Pharma, Inc. (BBIO) oscile entre $42.99 y $75.53.
Previsión mensual de BridgeBio Pharma, Inc. para 2026
En Oct de 2026, se proyecta que BridgeBio Pharma, Inc. promedie $49.52, con un mínimo de $42.99 y un máximo de $49.80.
En Nov de 2026, se proyecta que BridgeBio Pharma, Inc. promedie $56.66, con un mínimo de $55.17 y un máximo de $60.27.
En Dec de 2026, se proyecta que BridgeBio Pharma, Inc. promedie $62.38, con un mínimo de $54.39 y un máximo de $75.53.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.